223 related articles for article (PubMed ID: 24828665)
1. Radiation pneumonitis in patients with non--small-cell lung cancer treated with erlotinib concurrent with thoracic radiotherapy.
Zhuang H; Yuan Z; Chang JY; Wang J; Pang Q; Zhao L; Wang P
J Thorac Oncol; 2014 Jun; 9(6):882-5. PubMed ID: 24828665
[TBL] [Abstract][Full Text] [Related]
2. Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI).
Harada H; Seto T; Igawa S; Tsuya A; Wada M; Kaira K; Naito T; Hayakawa K; Nishimura T; Masuda N; Yamamoto N
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1777-82. PubMed ID: 21621337
[TBL] [Abstract][Full Text] [Related]
3. Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.
Nanda A; Dias-Santagata DC; Stubbs H; O'Hara CJ; Zaner KS; Lynch TJ; Willers H
Clin Lung Cancer; 2008 Sep; 9(5):285-7. PubMed ID: 18824451
[TBL] [Abstract][Full Text] [Related]
4. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
5. Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review.
Awad R; Nott L
Asia Pac J Clin Oncol; 2016 Mar; 12(1):91-5. PubMed ID: 26846159
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for treatment-related death associated with chemotherapy and thoracic radiotherapy for lung cancer.
Minami-Shimmyo Y; Ohe Y; Yamamoto S; Sumi M; Nokihara H; Horinouchi H; Yamamoto N; Sekine I; Kubota K; Tamura T
J Thorac Oncol; 2012 Jan; 7(1):177-82. PubMed ID: 22134071
[TBL] [Abstract][Full Text] [Related]
7. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
[TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
Su S; Li T; Lu B; Wang X; Li J; Chen M; Lu Y; Bai Y; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):769-77. PubMed ID: 26530745
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
Dandekar VK; Young J; Kiel K; Bonomi P; Fidler MJ; Batus M; Sher DJ
Am J Clin Oncol; 2015 Dec; 38(6):605-9. PubMed ID: 24781341
[TBL] [Abstract][Full Text] [Related]
10. Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy.
Jia W; Gao Q; Wang M; Li J; Jing W; Yu J; Zhu H
Radiat Oncol; 2021 Feb; 16(1):41. PubMed ID: 33622352
[TBL] [Abstract][Full Text] [Related]
11. [Correlations between Ape1/Ref-1, ICAM-1 and IL-17A Levels in Serum and Radiation Pneumonitis for Local Advanced Non-small Cell Lung Cancer Patients].
Guo L; Ding G; Xu W; Ge H; Jiang Y; Lu Y
Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):383-388. PubMed ID: 29764588
[TBL] [Abstract][Full Text] [Related]
12. Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer.
Amin NP; Miften M; Thornton D; Ryan N; Kavanagh B; Gaspar LE
Med Dosim; 2013; 38(3):320-6. PubMed ID: 23611631
[TBL] [Abstract][Full Text] [Related]
13. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
[TBL] [Abstract][Full Text] [Related]
14. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the radiation pneumonia development risk in lung cancer cases.
Yilmaz S; Adas YG; Hicsonmez A; Andrieu MN; Akyurek S; Gokce SC
Asian Pac J Cancer Prev; 2014; 15(17):7371-5. PubMed ID: 25227844
[TBL] [Abstract][Full Text] [Related]
16. Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.
Kwint M; Uyterlinde W; Nijkamp J; Chen C; de Bois J; Sonke JJ; van den Heuvel M; Knegjens J; van Herk M; Belderbos J
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e223-8. PubMed ID: 22560551
[TBL] [Abstract][Full Text] [Related]
17. Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment--case report.
Hsieh CH; Chang HT; Lin SC; Chen YJ; Wang LY; Hsieh YP; Chen CA; Chong NS; Lin SL; Chen CY; Shueng PW
BMC Cancer; 2010 Dec; 10():696. PubMed ID: 21194444
[TBL] [Abstract][Full Text] [Related]
18. Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy.
Zhuang H; Hou H; Yuan Z; Wang J; Pang Q; Zhao L; Wang P
Onco Targets Ther; 2014; 7():807-13. PubMed ID: 24920921
[TBL] [Abstract][Full Text] [Related]
19. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
[TBL] [Abstract][Full Text] [Related]
20. Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus Cisplatin followed by pemetrexed consolidation therapy in Japanese patients with locally advanced nonsquamous non-small-cell lung cancer.
Niho S; Kubota K; Nihei K; Sekine I; Sumi M; Sekiguchi R; Funai J; Enatsu S; Ohe Y; Tamura T
Clin Lung Cancer; 2013 Jan; 14(1):62-9. PubMed ID: 22633219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
